Sonde Health Buys Acquires NeuroLex Labs


Sonde Health, a Boston, MA-based vocal biomarker technology platform that detects health symptoms from a few seconds of voice, acquired NeuroLex Laboratories, Inc., a voice-enabled survey and data acquisition platform.

The amount of the deal was not disclosed.

In conjunction with the transaction, Jim Schwoebel, the chief executive officer of NeuroLex, will join Sonde’s leadership team as Vice President, Data and Research.

Sonde will acquire NeuroLex’s web-enabled voice survey and analysis platform, as well as its rich dataset, which when combined with its voice-based dataset, forms a preeminent biobank focused on vocal biomarkers. In addition, merging Sonde’s mobile and voice-assistant platforms with NeuroLex’s web-based capabilities will enable the delivery of voice-enabled heath detection and monitoring over any platform.

NeuroLex Laboratories is a digital health company applying speech analysis techniques to detect various health conditions early, before full-blown symptoms occur. Over the past two years, the company has built a large laboratories to collect, label, and model voice data tagged with health conditions comprised of over 40 research fellows across 12 universities that have published over 5 peer-reviewed journal articles. NeuroLex’s core product, SurveyLex, makes it easy to create and distribute voice surveys in less than a minute as URL links through web browsers. With this product, NeuroLex has curated a biobank comprised of over 500,000 voice samples from over 30,000 individuals alongside a host of pharmaceutical and academic partners.

Led by David Liu, CEO, Sonde Health leverages 300,000 voice samples from over 50,000 individuals to provide a proprietary voice-based technology platform that detects symptoms of health conditions – like depression and respiratory disease — from changes in voice. Using machine learning, Sonde senses and analyzes subtle vocal changes due to changes in a person’s physiology to provide early health detection and monitoring.

Sonde’s proprietary technology works by sensing and analyzing subtle changes in the voice due to changes in a person’s physiology. The company’s respiratory and depression health checks are available today.

Sonde One, the health screening app, uses vocal biometrics to help employers comply with government mandates and return to work safely. Sonde also has broad intellectual property coverage worldwide and licenses its technology through its API platform. 



Join the discussion